OREANDA-NEWS. Aptamers have been drawing the attention of several scientists in the last few years, not only because of their antibody replacement, but also because they have unique features, including low cost, thermal stability, and wide applications. Aptamers are oligonucleotides that bind to a particular target molecule. Aptamers exhibit high affinity and specificity to diverse target molecules, such as bacteria, proteins, or the whole cell. The growing interest of research scientists in aptamers is expected to encourage the growth of the overall market in the next few years. Moreover, the intensive research and development activities carried out by the key players for expansion of product portfolio and application will accelerate the growth of the market in the near future.
According to a research study released by Transparency Market Research (TMR), the global market for aptamers is estimated to reach a value of US$4.33 bn by the end of 2019, rising from US$93 mn in 2012. The market is predicted to register an exponential 73.10% CAGR between 2013 and 2019. In this blog, TMR provides answers to several questions concerning the remarkable growth of the global aptamers market, along with key dynamics that are projected to stimulate the growth of the market in the near future.
What are the primary aspects boosting the demand for aptamers in the global market?
The global market for aptamers is projected to witness positive growth, thanks to the rising investments in biotechnological and pharmaceutical companies. Furthermore, the aptamers market is projected to witness tremendous growth across the globe due to several advantages of aptamers over antibodies, including the ability to develop cost-effective and improved drugs and the ease of modification and synthesis. Nevertheless, the lack of knowledge and ethical hurdles are predicted to restrict the growth of the global aptamers market in the next few years.
How is the competitive landscape of the global aptamers market evolving?
NOXXON Pharma AG, Aptagen, Inc., Aptamer group, Somalogic, Inc., and Aptamer Sciences, Inc. are some of the prominent players operating in the global aptamers market. The global market for aptamers is expected to witness strong competition in the near future with the participation of several players operating in the market. The key players in the market are making notable efforts to introduce innovative products and improve the functionality and reduce efforts in postselection optimization. The increasing support of private organizations emphasizing on supporting advancements in aptamers technology is projected to contribute significantly towards the growth of the overall market in the coming years.
What is the scope of growth of the global aptamers market?
The emergence of the next generation of therapeutic aptamers and aptamer sandwich pairs is estimated to generate potential growth opportunities for the key players. Moreover, the introduction of aptamer sensors to bind protein ricin is expected to boost the demand for aptamers and the innovative biosensors in the near future. Technological advancements and the patent expiration of systematic evolution of ligands by exponential enrichment technology are also estimated to encourage the growth of the global aptamers market in the next few years.
With rising developments in place, numerous aptamers in clinical trials, and several others in the pipeline, the overall future of therapeutic aptamers appears exceptionally positive.